Upgrade to SI Premium - Free Trial

Stifel Reiterates Buy Rating on Crinetics (CRNX)

June 22, 2026 9:34 AM
Stifel analyst Alex Thompson reiterated a Buy rating and $83.00 price target on Crinetics (NASDAQ: CRNX).The analyst commented, " We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments